These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24928409)

  • 1. Prognostic evaluation of the troponin I elevation after multiple spontaneous shocks of the implantable cardioverter/defibrillator.
    Miranda CH; Schmidt A; Pazin-Filho A
    Am J Emerg Med; 2014 Sep; 32(9):1085-8. PubMed ID: 24928409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial injury secondary to ICD shocks: insights from patients with lead fracture.
    Sham'a RA; Nery P; Sadek M; Yung D; Redpath C; Perrin M; Sarak B; Birnie D
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):237-41. PubMed ID: 23998856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
    Sood N; Ruwald AC; Solomon S; Daubert JP; McNitt S; Polonsky B; Jons C; Clyne CA; Zareba W; Moss AJ
    Eur Heart J; 2014 Jan; 35(2):106-15. PubMed ID: 24179073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Effects of Implantable Cardioverter-Defibrillator Shocks on Biomarkers of Myocardial Injury, Apoptosis, Heart Failure, and Systemic Inflammation.
    Brewster J; Sexton T; Dhaliwal G; Charnigo R; Morales G; Parrott K; Darrat Y; Gurley J; Smyth S; Elayi CS
    Pacing Clin Electrophysiol; 2017 Apr; 40(4):344-352. PubMed ID: 28156007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study.
    D'Onofrio A; Russo V; Bianchi V; Cavallaro C; Leonardi S; De Vivo S; Vecchione F; Rago A; Ammendola E; Tavoletta V; Atripaldi L; Mocavero PE; Nigro G
    Europace; 2018 Sep; 20(FI2):f233-f239. PubMed ID: 29095967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of defibrillator shocks in patients with heart failure.
    Poole JE; Johnson GW; Hellkamp AS; Anderson J; Callans DJ; Raitt MH; Reddy RK; Marchlinski FE; Yee R; Guarnieri T; Talajic M; Wilber DJ; Fishbein DP; Packer DL; Mark DB; Lee KL; Bardy GH
    N Engl J Med; 2008 Sep; 359(10):1009-17. PubMed ID: 18768944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
    Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
    J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of inappropriate defibrillator shocks in a population cohort.
    Deyell MW; Qi A; Chakrabarti S; Yeung-Lai-Wah JA; Tung S; Khoo C; Bennett MT; Qian H; Kerr CR
    Heart; 2013 Sep; 99(17):1250-5. PubMed ID: 23468515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks.
    Hreybe H; Ezzeddine R; Barrington W; Bazaz R; Jain S; Ngwu O; Saba S
    Am J Cardiol; 2006 Feb; 97(4):544-6. PubMed ID: 16461053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure.
    Desai H; Aronow WS; Ahn C; Gandhi K; Hussain S; Lai HM; Sharma M; Frishman WH; Cohen M; Sorbera C
    Am J Cardiol; 2010 May; 105(9):1336-8. PubMed ID: 20403488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of acute cardiac and chest wall damage after shocks with a subcutaneous implantable cardioverter defibrillator in Swine.
    Killingsworth CR; Melnick SB; Litovsky SH; Ideker RE; Walcott GP
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1265-72. PubMed ID: 23713608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients.
    Larsen GK; Evans J; Lambert WE; Chen Y; Raitt MH
    Heart Rhythm; 2011 Dec; 8(12):1881-6. PubMed ID: 21816127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators.
    Daidoji H; Arimoto T; Nitobe J; Tamura H; Kutsuzawa D; Ishigaki D; Ishino M; Takahashi H; Shishido T; Miyashita T; Miyamoto T; Watanabe T; Kubota I
    J Card Fail; 2012 Jul; 18(7):556-63. PubMed ID: 22748489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
    Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
    Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks.
    Hasdemir C; Shah N; Rao AP; Acosta H; Matsudaira K; Neas BR; Reynolds DW; Po S; Lazzara R; Beckman KJ
    J Cardiovasc Electrophysiol; 2002 Feb; 13(2):144-50. PubMed ID: 11900289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.
    Barsheshet A; Moss AJ; Huang DT; McNitt S; Zareba W; Goldenberg I
    J Am Coll Cardiol; 2012 Jun; 59(23):2075-9. PubMed ID: 22651863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.